Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
About Index
Index
By TNW
Log in
Register
Nektar Therapeutics
3996
Nektar Therapeutics
Technology
Biotechnology
Nektar is a clinical-stage biopharmaceutical company developing a pipeline of drug candidates designed to improve the benefits of drugs for patients.
Suggest edits
Founded
1990
Raised
$45M
Follow us
Also headquartered in San Francisco
Ahelpfulghost
Twitter
Uber
Instagram
TikTok
Lyft
Airbnb
Coinbase
Fitbit
LinkedIn
Companies in the same industry
Diatherix Laboratories
Syneron Candela
Numira
V-Wave Medical
Inflexxion
AmpliPhi Biosciences
Blue Marble Energy
ChromoTek
Echometrix
Aprecia Pharmaceuticals
Alexa global traffic share
Twitter followers
Overview
Funding
2
Investments
1
Add info
Latest funding
$20,000,000
Post-IPO equity - 2016
$25,000,000
Venture capital - 2013
AstraZeneca
Team Size
500+
Employees
I work here
Location
San Francisco
,
United States
Headquarters
Explore San Francisco
$20,000,000
Post-IPO equity
Xconomy
Nektar Therapeutics Gets $20M in Daiichi Deal For Breast Cancer Drug
Health
The Motley Fool
Why Nektar Therapeutics Inc Is Dropping Today
The Motley Fool
Here's Why Nektar Therapeutics Inc. Rose 19% in March
The Motley Fool
Why Nektar Therapeutics Skyrocketed 30% Higher in October --
Stock markets
Health
